ENDRA Life Sciences (NDRA) Share-based Compensation (2016 - 2026)
ENDRA Life Sciences (NDRA) posted quarterly Share-based Compensation of $574451.0 for Q1 2026, up 591.73% year-over-year from $83046.0 in Q1 2025, and up 28225.99% quarter-over-quarter from $2028.0 in Q4 2025.
ENDRA Life Sciences (NDRA) Share-based Compensation (2016 - 2026) Analysis & Trends
ENDRA Life Sciences (NDRA) has reported Share-based Compensation for 11 consecutive years, with $574451.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Share-based Compensation rose 591.73% year-over-year to $574451.0; the TTM figure through Mar 2026 stood at $720774.0 (up 113.58% YoY), while the FY2025 annual figure was $329409.0, down 42.4% from the prior year.
- Share-based Compensation improved to $574451.0 in Q1 2026 per NDRA's latest filing, from $2028.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $909069.0 in Q3 2022 and bottomed at -$288537.0 in Q2 2022.
- Historically, Share-based Compensation has averaged $210118.4 across 5 years, with a median of $237279.0 in 2023.
- Annual changes were most pronounced in 2024 — Share-based Compensation plunged 114.58% — and 2026, when it jumped 591.73%.
- ENDRA Life Sciences' Share-based Compensation stood at $290769.0 in 2022, then dropped by 13.83% to $250557.0 in 2023, then sank by 58.22% to $104684.0 in 2024, then plunged by 98.06% to $2028.0 in 2025, then soared by 28225.99% to $574451.0 in 2026.
- Business Quant data shows NDRA's Share-based Compensation at $574451.0 in Q1 2026, $2028.0 in Q4 2025, and $104765.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 82.00 Mn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 93.00 Mn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 16.09 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 2.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 95.00 Mn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 774,000.00 |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 73.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 5.37 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 6.00 Mn |
| 10 | ENDRA Life Sciences | 5.44 Mn | 5.08 Mn | - | 574,451.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 574,451.00 |
| Mar 31, 2026 | 574,451.00 |
| Dec 31, 2025 | 2,028.00 |
| Dec 31, 2025 | 2,028.00 |
| Sep 30, 2025 | 104,765.00 |
| Sep 30, 2025 | 104,765.00 |
| Jun 30, 2025 | 39,530.00 |
| Jun 30, 2025 | 39,530.00 |
| Mar 31, 2025 | 83,046.00 |
| Mar 31, 2025 | 83,046.00 |
| Dec 31, 2024 | 104,684.00 |
| Dec 31, 2024 | 104,684.00 |
| Sep 30, 2024 | -36,847.00 |
| Sep 30, 2024 | -36,847.00 |
| Jun 30, 2024 | 186,590.00 |
| Jun 30, 2024 | 186,590.00 |
| Mar 31, 2024 | 317,497.00 |
| Mar 31, 2024 | 317,497.00 |
| Dec 31, 2023 | 250,557.00 |
| Dec 31, 2023 | 250,557.00 |